TRAW

Traws Pharma, Inc.

TRAW · CIK 1130598 · Annual (10-K) · Last 8 years

Financial Trends

Revenue$0M
20172024
Net Income−$167M
20172024
Operating CF−$30M
20172024
Free Cash Flow−$30M
20172024

Income Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Revenue$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Cost of Revenue————————
Gross Profit————————
R&D Expense—$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
SG&A Expense————————
Operating Income$-0.1B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Net Income$-0.2B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
EPS (Basic)$-35.21$-0.90$-0.91$-0.96————
EPS (Diluted)$-35.21$-0.90$-0.91$-0.96————

Balance Sheet

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Total Assets$0.0B$0.0B$0.0B$0.1B$0.0B$0.0B$0.0B$0.0B
Current Assets$0.0B$0.0B$0.0B$0.1B$0.0B$0.0B$0.0B$0.0B
Cash & Equivalents—$0.0B$0.0B—————
Total Liabilities$0.1B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Current Liabilities$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity—————$0.0B$0.0B$-0.0B

Cash Flow Statement

MetricFY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕FY 2019↕FY 2018↕FY 2017↕
Operating Cash Flow$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B$-0.0B
Investing Cash Flow$-0.0B$-0.0B—$-0.0B$-0.0B$-0.0B——
Capital Expenditures$0.0B$0.0B—$0.0B$0.0B$0.0B——
Financing Cash Flow$0.0B—$0.1B$0.1B$0.0B$0.0B$0.0B$0.0B
← Companies